Long-term mortality after myocardial infarction is reduced by trandolapril

Among 1749 patients in the TRACE study followed for a minimum of six years, treatment with trandolapril improved life expectancy by 15.3 months (6.2 versus 4.6 years for placebo). The number of lives saved per 1000 people treated are shown for each year.